Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: J Antibiot (Tokyo). 2012 Sep 12;65(11):559–564. doi: 10.1038/ja.2012.69

Table 1.

NMR data for compound 1 [in CDCl3, 500 (1H) and 125 (13C) MHz, chemical shifts in δ, coupling constants in Hz]

Position δC δH, Mult.(J in Hz) HMBC (H → C)
1, 1′ 167.3
3, 3′ 77.0
4, 4′ 161.5
5a, 5a′ 82.1 5.7, s 6a, 10a, 10b, 11a
6a, 6a′ 148.9
7, 7′ 110.9 6.7, d (8.0) 8, 9, 10a
8, 8′ 130.1 7.1, ddd (8.0, 7.6, 1.1) 6a, 10
9, 9′ 120.5 6.8, ddd (8.0, 7.6, 1.1) 7, 8, 10a
10, 10′ 128.3 7.8, d (7.6) 6a, 10a
10a, 10a′ 129.5
10b, 10b′ 65.8
11, 11′ 83.3 5.2, s 5a, 10b
11a, 11a′ 77.5
12, 12′ 28.1 3.0, s 1, 3
13,13′ 24.6 a 2.4, b 2.1, dd (14.5,7.3) 3, 4, 14
14,14′ 9.9 1.2, d (7.3) 3, 13
OH-11, OH-11′ 5.1, s
NH-6, NH-6′ 5.6, s 5a

Abbreviations: Mult., multiplicity.

HHS Vulnerability Disclosure